Obinutuzumab may chart the way to improved QOL for CLL patients

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)113-114
Number of pages2
JournalJournal of Community and Supportive Oncology
Volume12
Issue number4
DOIs
StatePublished - Apr 2014
Externally publishedYes

Fingerprint

obinutuzumab

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Obinutuzumab may chart the way to improved QOL for CLL patients. / Awan, Farrukh T.

In: Journal of Community and Supportive Oncology, Vol. 12, No. 4, 04.2014, p. 113-114.

Research output: Contribution to journalComment/debate

@article{af5471b96b3c41c996bad4568fdcc8d3,
title = "Obinutuzumab may chart the way to improved QOL for CLL patients",
author = "Awan, {Farrukh T.}",
year = "2014",
month = "4",
doi = "10.12788/jcso.0030",
language = "English (US)",
volume = "12",
pages = "113--114",
journal = "Journal of Community and Supportive Oncology",
issn = "2330-7749",
publisher = "Frontline Medical Communications",
number = "4",

}

TY - JOUR

T1 - Obinutuzumab may chart the way to improved QOL for CLL patients

AU - Awan, Farrukh T.

PY - 2014/4

Y1 - 2014/4

UR - http://www.scopus.com/inward/record.url?scp=84988462385&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988462385&partnerID=8YFLogxK

U2 - 10.12788/jcso.0030

DO - 10.12788/jcso.0030

M3 - Comment/debate

C2 - 24971418

AN - SCOPUS:84988462385

VL - 12

SP - 113

EP - 114

JO - Journal of Community and Supportive Oncology

JF - Journal of Community and Supportive Oncology

SN - 2330-7749

IS - 4

ER -